Published 31 October 2026 · Reviewed by Dr Sin Yong
You are likely to be suitable for Juvelook when your concern is skin quality, such as fine lines, crepey texture or thin skin, and you accept a gradual change from a product that cannot be fully dissolved. Sagging is a lifting problem, not a Juvelook one. Pregnancy, inflamed skin and earlier filler of unknown type mean waiting. Dr Sin Yong decides at examination.
Short answerJuvelook is poly-D,L-lactic acid (PDLLA) microspheres carried in non-cross-linked hyaluronic acid, made by VAIM in Korea. Hyaluronidase dissolves the hyaluronic acid but not the PDLLA. Dr Sin Yong can use it, including under the eyes, but often prefers energy-based treatment. This page sits under Juvelook in Singapore.
Juvelook is a skin-quality tool first. It sits between a skin booster and a volumising filler: the hyaluronic acid in the vial gives some hydration on the day, and the PDLLA prompts the skin to lay down its own collagen gradually. That makes it a candidate for fine lines, crepey or thin skin and fine texture, in someone who accepts gradual change rather than an immediate one.
Illustrative image — not a patient.
There are two products. Juvelook, the 50 mg vial, is used for skin quality. Juvelook Volume, sold internationally as Lenisna, carries more PDLLA per vial and is used where structure, rather than surface quality, is the aim. Which one, if either, fits depends on whether the concern is the skin, the volume beneath it, or both.
Suitability also means accepting what the product is. Hyaluronidase dissolves Juvelook's hyaluronic acid carrier but not the PDLLA, so it is not a fully reversible treatment. The published evidence is early and small: a 2024 literature review of PDLLA in dermatology described its structure and uses, and studies so far are case series and case reports, with no randomised trial comparing Juvelook with Sculptra or with hyaluronic acid filler.
Skin quality, volume or sagging: what Juvelook answers
Dr Sin Yong starts by deciding whether the problem is skin quality, volume or laxity, because Juvelook answers the first two and sagging is a lifting problem.
What the examination finds
Juvelook?
What is weighed instead or alongside
Fine lines, crepey or thin skin, fine texture
Yes, often
FSX Laser, which Dr Sin Yong often prefers for the skin because nothing is injected
Deeper volume or contour change
Juvelook Volume is considered
Filler for a defined deficit, or Sculptra for gradual volume
A hollow under the eyes
Possible, with care
The Restore mode of the VF Lift – Vertical Facelift, often preferred for hollow areas
Sagging along the jaw or cheeks
No
A lifting treatment, such as the VF Lift or focused ultrasound
A heavy face from injectables layered over the years
No; more product is the wrong answer
Ultrasound mapping, then dissolving hyaluronic acid or the Sculpting mode of Time Freeze Laser LCLR® for collagen stimulators
Dull, dehydrated skin wanting hydration
Sometimes
A hyaluronic acid skin booster or Profhilo, which add no collagen stimulator
“Juvelook answers skin quality. If the real problem is sagging, more product is the wrong answer, and I would rather say so before the vial is opened.”
Dr Sin YongOn who suits Juvelook
When Juvelook is not the right choice, and who should wait
Reasons to wait
Pregnancy and breastfeeding. Collagen stimulators are deferred until afterwards.
Infection or inflammation in the area, including an acne flare or a cold sore, until the skin has settled.
Discussed first, and can rule it out
Allergy to a component.
A tendency to keloid or raised scarring.
Earlier filler or collagen stimulator of unknown type. It is assessed, with ultrasound where needed, before anything new is added, because collagen stimulators and hyaluronic acid layered over time are a common reason faces look heavy.
Not the right tool
Sagging as the main concern.
Wanting a result that can be fully reversed.
Heavy skin excess that no injectable can lift, where a surgical opinion is advised.
Nodules can occur with any collagen stimulator, including PDLLA. A 2025 case report described firm, non-inflammatory nodules after PDLLA in the tear trough that resolved after treatment with a monopolar radiofrequency device. That risk is discussed before treatment, and it is one reason the under-eye area is approached with particular care. What is expected afterwards and what is not is on Juvelook side effects.
What is checked before Juvelook is planned
What has been injected before. Products, areas and dates, as far as you know them. Bring any records.
Ultrasound where earlier product is suspected, to see where it sits, how deep and what it is likely to be.
Skin, volume or laxity. The face is examined to decide which of the three is driving the concern.
Allergies, scarring and healing, including any keloid tendency.
Pregnancy, breastfeeding and the skin on the day, including acne flares and cold sores.
Placement, dilution and the number of visits are set after examination; this site does not publish session counts. You leave with a written plan that names the product proposed and why that rather than a skin booster or Sculptra, what it cannot do for you, the risks including nodules, and the alternatives considered, including no injection.
If Juvelook is not suitable: the alternatives
Dr Sin Yong prefers energy-based treatment for many concerns that injectables are used for, because nothing is added that could cause pillow face, migration or lumps.
Hydration and crepey skin with a reversible product: Profhilo or a hyaluronic acid skin booster; for repair of thin skin, a polynucleotide such as Rejuran.
Gradual volume: Sculptra, after its own suitability assessment.
A defined volume deficit with reversibility: hyaluronic acid filler, which hyaluronidase can dissolve.
Sagging: a lifting treatment rather than any injectable.
Where excess Juvelook has been placed elsewhere, the plan is correction rather than more product, as described on Juvelook lumps.
Your next step
1. MessageWhatsApp +65 8023 7170 with what is bothering you. A reply comes from the clinic, not a bot.
2. AssessmentDr Sin Yong examines you himself on Orchard Road, with ultrasound where earlier filler is involved.
3. A plan in writingWhat he would do, what he would not, the fee factors, and the option of no treatment.
Every treatment is performed by Dr Sin Yong personally. Singapore Medical Council registered · invited to share his clinical expertise internationally for CLASSYS, DEKA, Fotona, Hironic and Ilooda.
Book an assessment with Dr Sin Yong on Orchard Road; bring any records of earlier fillers or collagen stimulators. How consultations work.
Dr Sin Yong can use Juvelook under the eyes for skin quality and fine texture, but he often prefers energy-based treatment there: FSX Laser for the skin and the Restore mode of the VF Lift – Vertical Facelift for hollow areas. Nodules can occur with any collagen stimulator, and the PDLLA cannot be dissolved, so the under-eye area is assessed with particular care.
Not for the sagging. Juvelook answers skin quality and, as Juvelook Volume, some structure, but sagging is a lifting problem, and more product is the wrong answer to it. Laxity along the jaw or cheeks is assessed for a lifting treatment such as the VF Lift – Vertical Facelift or focused ultrasound. Skin quality can be planned alongside, once the lift is decided.
Often, once the earlier product has been assessed. Filler or collagen stimulator of unknown type is checked with ultrasound where needed before anything new is added, because layering products over time is a common reason faces look heavy. Where excess is found, it is managed first, by dissolving hyaluronic acid or with Time Freeze Laser LCLR® for collagen stimulators.
It depends on what the skin is short of. A skin booster such as Profhilo or a polynucleotide places hydrating or regenerative material into the skin and is not designed to build volume. Juvelook adds a collagen stimulator, PDLLA, that cannot be dissolved. Where reversibility matters or hydration is the main need, a booster is usually weighed first.
Juvelook is deferred in pregnancy and breastfeeding and while there is infection or inflammation in the area, including an acne flare or a cold sore. Allergy to a component or a tendency to keloid scarring is discussed first and can rule it out. It is the wrong choice where sagging is the main concern, or where a fully reversible result is wanted.
References
Poly-d,l-lactic Acid (PDLLA) Application in Dermatology: A Literature Review. Polymers 16(18), 2024. source
Evaluating Poly-D,L-Lactic Acid for Lower Eyelid Rejuvenation: Efficacy and Safety. Journal of Cosmetic Dermatology 24(3), 2025. source
Energy-Based Device Management of Nodular Reaction Following Poly-D, L-Lactic Acid Injection for Tear Trough Rejuvenation. Journal of Cosmetic Dermatology 24(1), 2025. source
About this page: written and medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last reviewed 6 November 2026 · Illustrative images only, not patients · Editorial policy
